Gastric Band

Summary: A gastric band is an inflatable silicone ring placed around the upper stomach to limit food intake. Apollo Endosurgery discontinued LAP-BAND production in 2023 and the procedure now represents under 1% of US bariatric surgeries, with sleeve gastrectomy and GLP-1 medications taking its place.

This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.

The gastric band is an adjustable silicone ring placed around the upper stomach to slow eating and create early fullness. In 2026 it is functionally obsolete. Apollo Endosurgery stopped producing the LAP-BAND System in 2023, the only band still approved in the United States. Fewer than 1% of US bariatric operations are now bands, down from a peak of roughly 35% in 2011 [2]. The replacement is sleeve gastrectomy, which delivers more weight loss with a fraction of the reoperation rate.

This page covers what the device was, how the procedure worked, what kind of results patients actually got, why the complication rate sank the band, and what a patient with an existing band should know in 2026.

What the gastric band was

The adjustable gastric band, marketed in the US as the LAP-BAND System, is an inflatable silicone ring placed laparoscopically around the upper portion of the stomach. It creates a small pouch above the band that fills quickly during a meal, sending early satiety signals to the brain. The band connects through thin tubing to a port sutured just beneath the skin of the abdomen. A clinician adjusts band tightness by injecting saline into that port with a non-coring needle.

The FDA approved the LAP-BAND in June 2001. A second device, the Realize Band by Ethicon, was approved in 2007 but lost FDA approval in 2016 and was withdrawn from the market. From 2016 until 2023, the LAP-BAND was the only adjustable band available in the United States.

Two important properties separated the band from other bariatric operations. It did not cut, remove, or reroute any part of the stomach or intestine. And it was reversible, at least in theory, with another laparoscopic procedure to take the band out.

The adjustable gastric band procedure

The procedure took 30 to 60 minutes under general anesthesia. The surgeon made three to five small keyhole incisions in the abdomen, insufflated the cavity with carbon dioxide, and inserted a laparoscope. A small tunnel was created behind the upper stomach, the band was passed through and locked around the gastric fundus just below the gastroesophageal junction, and the port was sutured to the abdominal wall fascia.

Most patients went home the same day. Normal activity resumed in about a week, and the first band fill happened six to eight weeks later, after the surgical site had healed and any tissue swelling had resolved. Subsequent adjustments were done in an office visit with a fine needle into the port. The band typically held 4 to 12 cc of saline depending on the model.

A typical post-operative diet progression looked like this.

PhaseTimingDiet
Stage 1Days 1 to 7Clear liquids and thin broths
Stage 2Weeks 2 to 4Pureed foods, yogurt, blended soups
Stage 3Weeks 4 to 6Soft foods, well-cooked vegetables, soft proteins
Stage 4Week 6 onwardSolid foods in small portions, careful chewing

The "8 golden rules" of band living, taught by most bariatric programs, were: eat three small meals daily, eat slowly and chew thoroughly, stop at the first sense of fullness, do not drink with meals, choose high-protein foods first, avoid soft high-calorie foods like ice cream that slip through the band, exercise daily, and attend every follow-up adjustment. Patients who broke these rules lost less weight and had more complications.

What gastric bands actually delivered

The honest number for average weight loss is 40 to 50% of excess body weight at one to two years, with a meta-analysis by Buchwald putting the figure at 47.5%. For a person 100 pounds over their ideal weight, that is 40 to 50 pounds lost. Sleeve gastrectomy and Roux-en-Y gastric bypass routinely produce 60 to 70% excess weight loss over the same period.

The bigger problem was durability. The longest published follow-up data from a New York state cohort of 19,221 band patients showed reoperation rates climbing year over year, with roughly 35 to 40% of bands removed by ten years [4]. A separate single-center series published in Surgery for Obesity and Related Diseases reported failure rates above 50% within five years when the band was used as a primary bariatric procedure [5].

Common reasons for band removal:

  • Inadequate weight loss or weight regain
  • Band slippage with pouch dilation
  • Band erosion through the stomach wall
  • Severe gastroesophageal reflux disease (GERD)
  • Esophageal dilation and dysmotility
  • Port site infection or mechanical failure
  • Patient intolerance

When the band came out, many patients went on to a second bariatric operation, usually a sleeve gastrectomy. The two-stage approach (band out, sleeve in) carried higher complication rates than going straight to a sleeve in the first place.

Why the band was discontinued

Apollo Endosurgery acquired the LAP-BAND System from Allergan in 2013, when annual US placements had already begun their long slide from their 2011 peak. By the early 2020s, demand was so low that fewer than 1,000 bands were being placed nationally per year [2]. In 2023, Apollo announced it would stop selling the device. The decision matched the trajectory the American Society for Metabolic and Bariatric Surgery had been describing in its annual procedure counts for over a decade.

Three forces killed the band.

First, the complication and reoperation data was unambiguous by the mid 2010s. Long-term follow-up kept showing that bands needed to be removed or revised at rates several times higher than sleeves or bypasses, with worse weight loss to show for the trouble.

Second, the sleeve gastrectomy took over. Approved as a stand-alone bariatric procedure in 2009 and rapidly adopted, the sleeve is technically straightforward, produces durable weight loss, and avoids the foreign-body and adjustment-burden problems of the band. By 2022, sleeves were roughly 60% of all US bariatric operations [2].

Third, GLP-1 receptor agonists. Semaglutide (Wegovy) was approved for chronic weight management in 2021. Tirzepatide (Zepbound) followed in late 2023. Both deliver 15 to 22% mean total body weight loss in pivotal trials, comparable to or exceeding what the average band patient achieved, without surgery and without an implanted device. The procedural bariatric pipeline contracted because medical options finally caught up with restrictive surgery.

The 2022 ASMBS and IFSO updated indications for metabolic and bariatric surgery effectively dropped the band from routine recommendation, noting that more durable procedures should be preferred for patients meeting surgical criteria [3].

Are gastric bands safe? The complication profile

The band always had two safety pitches. Perioperative mortality was low, around 1 in 2000 procedures, and the operation itself was technically simpler than a bypass. Both points are true. The problem is that "safe in the operating room" is not the same as "safe over a lifetime."

The FDA's documented adverse effects for adjustable gastric bands include, in addition to the routine surgical risks of bleeding, infection, and anesthesia complications:

  • Band slippage and pouch dilation
  • Erosion of the band into the gastric lumen
  • Esophageal dilation and dysmotility
  • Severe gastroesophageal reflux
  • Stoma obstruction
  • Mechanical port and tubing failures (leakage, kinking, disconnection)
  • Port site infection and skin erosion
  • Band intolerance with persistent nausea
  • Aspiration pneumonia from chronic regurgitation

The cumulative probability of any of these occurring rose with time. Studies that followed patients past five years consistently put the rate of one or more major complications above 30%, with some series exceeding 50% at ten years [4][5].

What sleeve gastrectomy did differently

Sleeve gastrectomy removes roughly 75 to 80% of the stomach along the greater curvature, leaving a narrow tubular sleeve that holds 100 to 150 mL instead of 1,400 mL. There is no foreign body, no adjustment needed, and the removed portion includes much of the ghrelin-producing tissue, so appetite hormones change in ways that support sustained weight loss.

A direct comparison of the two procedures helps explain why the field moved.

MetricAdjustable gastric bandSleeve gastrectomy
Excess weight loss at 2 years40 to 50%60 to 70%
Reoperation rate at 10 years35 to 50%Under 10%
Hospital staySame day to 1 night1 to 2 nights
ReversibleYes (band removal)No (stomach is removed)
Foreign bodyYes (silicone band, port, tubing)No
Nutrient malabsorptionNoneMinor (B12, iron, vitamin D)
Hormonal effectMinimal (restrictive only)Ghrelin reduction, GLP-1 increase
US procedure share, 2022Under 1%About 60%

The sleeve is not reversible, which is a real trade-off. But the reoperation data shows that bands are not reliably reversible either. When a band needs to come out for complications, the patient often loses the weight benefit and faces a second operation anyway.

If you already have a gastric band

A band placed years ago does not need to come out just because the device is no longer being manufactured. Apollo committed to honoring service and support obligations through the discontinuation, and the implanted silicone itself does not have a fixed shelf life. Many people still living with functional bands continue to do well.

What changes is the calculus around problems. If your band is causing GERD, dysphagia, port issues, or has stopped supporting weight loss, the modern decision is usually band removal with conversion to either a sleeve gastrectomy or, in the right patient, a Roux-en-Y gastric bypass. Bariatric surgeons doing band-to-sleeve revisions report good outcomes, though the second operation has higher complication rates than a primary sleeve.

For patients whose only issue is weight regain after a band that is otherwise behaving, GLP-1 medication is now a reasonable conversation. Semaglutide and tirzepatide have data in post-bariatric patients, and they can be used alongside an existing band without device-related interactions. Always discuss with the bariatric surgeon who knows your anatomy.

Routine band imaging in 2026 still looks the same as it always did. Normal gastric band radiology shows a closed silicone ring at the proximal stomach, tubing tracking laterally to a subcutaneous port, and no extravasation of contrast on a swallow study. Slippage shows up as a band that has rotated or migrated distally, with an enlarged pouch above. Erosion is diagnosed on endoscopy when the band becomes visible inside the gastric lumen.

Discharge instructions and follow-up that used to be standard

For patients who underwent laparoscopic adjustable gastric band surgery, the standard discharge instructions covered:

  • Liquid diet for the first 1 to 2 weeks, advancing per the bariatric team's protocol
  • No lifting more than 10 to 15 pounds for 4 to 6 weeks
  • Walking the day of surgery to reduce blood clot risk
  • Avoiding NSAIDs because of ulcer risk near the band site
  • Monitoring port site incisions for redness, drainage, or fever
  • Returning for the first fill at week 6 to 8
  • Lifelong follow-up with a bariatric program for adjustments, nutritional monitoring, and complication surveillance

The lifelong follow-up burden was one of the band's quiet downsides. Sleeve and bypass patients still need follow-up, but bands required active management of the device itself in a way the others did not.

Gastric band cost and insurance

When the band was a mainstream procedure, US cash-pay costs ranged from about $9,000 to $20,000 depending on the program, surgeon, and geography. Insurance coverage was common when the patient met standard bariatric criteria (BMI 40 or higher, or BMI 35 to 39.9 with a qualifying comorbidity, plus documented failure of conservative weight loss attempts).

By 2026 many insurance plans no longer cover primary band placement, citing the long-term reoperation data and ASMBS guidance. Band removal and revision to sleeve or bypass is typically covered when medically indicated. GLP-1 coverage for obesity continues to expand, though prior authorization criteria vary widely.

Common questions about gastric bands

Are gastric bands still available in 2026?
Apollo Endosurgery discontinued LAP-BAND production in 2023 and it was the last band approved in the US. New band placements are now extremely rare. Existing patients still receive follow-up care.
Do gastric bands work?
Yes, modestly. Average excess weight loss is 40 to 50%, less than sleeve gastrectomy or bypass. Long-term follow-up shows 35 to 50% of bands are removed within ten years for complications or inadequate weight loss.
Is a gastric band an extraluminal device?
Yes. The band sits outside the stomach wall, encircling the upper stomach. That distinguishes it from intragastric balloons, which are placed inside the stomach lumen.
What are the 8 golden rules for living with a gastric band?
Eat three small meals daily, eat slowly, chew thoroughly, stop at first fullness, do not drink with meals, prioritize protein, avoid soft high-calorie foods, exercise daily, and attend all follow-up adjustments.
How does adjustable gastric band procedure compare to bariatric surgery gastric banding terminology?
They refer to the same operation. "Adjustable gastric band" emphasizes the device, "gastric banding surgery" emphasizes the procedure. Both describe the laparoscopic placement of a silicone band around the upper stomach.
What does a normal gastric band look like on radiology?
A closed silicone ring at the proximal stomach, with thin tubing tracking laterally to a subcutaneous port. A normal swallow study shows contrast passing freely through the stoma into the lower stomach without obstruction or pouch dilation.
Should I get a gastric band in 2026?
Almost certainly not. The device is no longer manufactured in the US, the long-term complication rate is high, and modern alternatives (sleeve gastrectomy, GLP-1 medications like semaglutide and tirzepatide) deliver better weight loss with fewer device-related problems.
Can GLP-1 medications replace gastric band surgery?
For many patients, yes. Semaglutide and tirzepatide produce 15 to 22% total body weight loss in pivotal trials, matching or exceeding average band results without surgery. They are not surgical replacements in every case but have shifted the threshold for choosing surgery.
What happens if I get pregnant with a gastric band?
Most surgeons recommend deflating the band before or early in pregnancy to allow adequate nutrition. The band can be re-inflated after delivery and weaning. Rapid post-band weight loss raises fertility, so contraception planning matters.
Is the LAP-Band the same as gastric bypass?
No. The band is a restrictive device placed around the outside of the stomach. Gastric bypass divides the stomach into a small pouch and reroutes the small intestine. Bypass produces more weight loss and more metabolic effect, with a more involved operation.

Bottom line

The gastric band was a reasonable idea in 2001 and a mainstream procedure for about a decade. The long-term data brought it down. By 2026 the device is discontinued, the procedure is rare, and patients seeking weight loss have better options: sleeve gastrectomy when surgery is right, and GLP-1 receptor agonists when it is not. Anyone with an existing band should stay in follow-up with a bariatric program, monitor for late complications, and discuss conversion or medication if results are slipping.

References

  1. Apollo Endosurgery, LAP-BAND System discontinuation notice and product update
  2. American Society for Metabolic and Bariatric Surgery, Estimate of bariatric surgery numbers, 2011 to 2022
  3. Eisenberg D et al, 2022 ASMBS and IFSO Indications for Metabolic and Bariatric Surgery, Surgery for Obesity and Related Diseases
  4. Altieri MS, Yang J, Telem DA et al, Lap band outcomes from 19,221 patients across centers and over a decade within the state of New York, Surgical Endoscopy 2016
  5. Kindel T, Martin E, Hungness E, Nagle A, High failure rate of the laparoscopic-adjustable gastric band as a primary bariatric procedure, Surgery for Obesity and Related Diseases 2014